Fellowship · Mount Laurel, NJ
Sponsored by Cooper Medical School of Rowan University/Cooper University Hospital
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials.
Lancet (London, England) · 2025 · 37 citations · Leonardo Salese
Preventive Measures and Risk Factors for Post-ERCP Pancreatitis: A Systematic Review and Individual Patient Data Meta-Analysis.
Digestive diseases and sciences · 2024 · 28 citations · Shaffer Mok
Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis.
European journal of gastroenterology & hepatology · 2025 · 24 citations · Fariha Hasan
Biofilms as Battlefield Armor for Bacteria against Antibiotics: Challenges and Combating Strategies.
Microorganisms · 2023 · 32 citations · Fariha Hasan
A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts.
Annals of surgery · 2023 · 49 citations · Shaffer Mok
Efficacy and Safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor Necrosis Factor Inhibitor Failure Status.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2022 · 62 citations ·
Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program.
Inflammatory bowel diseases · 2023 · 34 citations · Leonardo Salese
Risk factors for biliary strictures and leaks after living-donor liver transplantation: a systematic review and meta-analysis.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2024 · 12 citations · Michael Rosenheck